Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
blarcamesine (9 trials)
anavex3-71 (1 trial)
ketamine (ketalar) (1 trial)
Alzheimer Disease (Phase 3)
Dementia (Phase 2)
Parkinson Disease (Phase 2)
Rett Syndrome (Phase 3)
Syndrome (Phase 3)
Trials (11 total)
Trial APIs (3 total)